4//SEC Filing
BOUDREAUX GAIL 4
Accession 0001156039-24-000109
CIK 0001156039other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:02 PM ET
Size
15.0 KB
Accession
0001156039-24-000109
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-07-22$501.40/sh−6,621$3,319,769→ 132,209 total - Sale
Common Stock
2024-07-22$503.67/sh−1,000$503,670→ 128,959 total - Sale
Common Stock
2024-07-22$502.23/sh−2,250$1,130,018→ 129,959 total - Sale
Common Stock
2024-07-22$504.27/sh−2,250$1,134,608→ 126,709 total - Sale
Common Stock
2024-07-22$498.50/sh−1,100$548,350→ 159,609 total - Sale
Common Stock
2024-07-22$500.36/sh−20,779$10,396,980→ 138,830 total
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001287920
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 5:02 PM ET
- Size
- 15.0 KB